MiNK Therapeutics INKT
NASDAQ INKT
$12.44 -0.29 (-2.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Price to Book (2021 - 2022)

Updated

MiNK Therapeutics' (INKT) Price to Book was 10.55 for Q3 2022, up 203.3% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Price to Book (2021 - 2022) Analysis & Trends

For FY2021, Price to Book at MiNK Therapeutics was 4.88.

  • Per Business Quant data, the three quarters before Q3 2022 came in at 3.48 (Q2 2022), 4.36 (Q1 2022) and 4.88 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 MiNK Therapeutics 64.88 Mn 64.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 10.55
Jun 30, 2022 3.48
Mar 31, 2022 4.36
Dec 31, 2021 4.88
API Access

MiNK Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=INKT&period=max&api_key=YOUR_API_KEY